- The value of patient-centered design in hospitals
When speaking of design in hospitals, most people think about interior design, but this evening, we like to speak about the design of services, processes and the whole experience of being in a hospital. There are not many touch points in which processes are more cost-driven and over-regulated as in hospitals. On the other side, there are also not many touch points in the healthcare ecosystem which are more connected to fear, uncertainty and other strong emotions for the patients and their relatives. Together we will learn about patient-centred design methods for designing hospital processes and services. By applying these, hospitals can get more efficient and pleasant for patients, relatives as well as healthcare professionals. Speakers: Emile Strømmen Olsen, Designit, Oslo Emile is an experienced and empathic Senior Service Designer from the Designit office in Oslo. Emilie places great importance on user involvement in the process. Emilie is an expert in executing user research, facilitating workshops and keeping a holistic eye in the projects. She will talk about a case for breast cancer patients at the Oslo University Hospital, the largest hospital in Scandinavia. Designit created a process to reduce the time from referral to diagnosis by 90%, and improved the overall experience for the patients during their hospital stay. Yasmina Haryono Yasmina is heading design at smart Helios. Prior to joining smart Helios, she has worked in design and product management roles for startups, agencies and corporates. Anja Mayr Anja is senior UX Researcher for smart Helios. She has been working as Service & UX Designer/Researcher and Innovation Consultant in digital product development & agencies for the past 7+ years. Smart Helios (https://smarthelios.de/en/) is a spin-off from Helios Kliniken, Europe’s leading private hospital group. Smart Helios develops digital solutions for patients and their family members and both, Anja and Yasmina, will tell us more about their work. Jan Simon Raue Jan Simon is co-founder and managing director of Fosanis. Fosanis is developer of Mira (www.mira-app.com), a platform supporting cancer patients by providing mental support and practical guidance for patients facing a challenging time in their lives. Prior to Fosanis, Jan Simon worked as a strategy consultant at OC&C and co-founded AdvoAssist, a leading German legaltech platform. He holds a PhD from the Technical University of Berlin. Harun Badakhshi Harun is working as chief physician & director of clinical oncology at the Ernst von Bergmann Medical Center, an academic teaching hospital of Humboldt University Berlin (Charité), and is teaching at the Medical School Charité in Berlin. The Health 2.0 Berlin team thanks Designit (https://www.designit.com/) for co-organizing and co-hosting this meetup.
- Launching in the USA: Perspectives & advice on market expansion into the US
This time we will be looking to the US and what you should know before bringing your startup overseas. Topics to be discussed at the meetup: - When does a market expansion to the US make sense? - Who are the real purchasers of digital healthcare products- contrasts of the US vs Germany? - Success factors and challenges for launching in the US - Predictions on VC investments in digital healthcare, which subcategories are increasing or decreasing in US investment value - US healthcare regulations and its effect on healthcare startups Panelists: - Rashida Bobb - Founder of BricksHealth, American, Specialist in market development & commercialization strategy for digital healthcare companies. Rashida has consulted for Pfizer, Roche, Peppermint Venture Funds and Germany based digital healthcare startups. - Mike Doherty - American, founder of Doherty & Associates, has a long history of business development, strategy, and planning. Mike has consulted for the EU Union (Horizons 2020), Enpact e.V. and globally with individual companies. He has also worked as an investor and a lender and therefore recognizes the demands and expectations these parties bring to the mix. - Nina Kiwit - COO at iRewardHealth GmbH, Nina Kiwit currently manages the iRewardHealth operations in Germany, which offers a self-tracking health bonus app for employees and insured persons. The app is designed to build healthy habits in everyday life situations and to help users developing a health consciousness. Previously, Nina Kiwit studied International Business and Public Health with a focus on e-health, which she is now using to further advance the path to digital health in Europe. Moderator: - Naomi Kresge, Journalist at Bloomberg LP - Naomi Kresge is a health-care reporter at Bloomberg, the global financial newswire. She joined Bloomberg in 2008 and has worked in Zurich and Berlin, covering the European biotechnology and pharmaceutical industry. She also spent two years as an automotive editor and deputy team leader, assisting with coverage of the Volkswagen diesel scandal. The event will be in English. Agenda: 18:30 Doors open 19:00 Panel discussion 20:15 Networking
- End of life - what value can technology-enabled services provide?
We are starting the new year with a very important topic, though often pushed to the sides and well - to the end. In our society we would like to ignore death and when it happens it makes us feel uncomfortable. Can technology/enabled services change that dynamic? What value does technology provide for end of life decisions? We invited a panel of founders and experts who shape great products that support people and their loved ones during the end of life and death. Speakers: Paul Brandenburg, CEO @ Dipat - Die Patientenverfügung, https://www.dipat.de/ Björn Krämer, Founder @ MYMORIA GmbH, https://www.mymoria.de Prof. Dr. Thomas Meyer, CEO @ Ambulanzpartner.de https://www.ambulanzpartner.de/ & Director @ Ambulanz für ALS und andere Motoneuronenerkrankungen, Charité www.als-charite.de Leon Bichler, Founder @ LifeCompanion App https://www.lifecompanion.eu/ Moderator: Patricia Ex, Managing Director @ Bundesverband Managed Care, http://www.bmcev.de The meetup will be in German. Agenda: 18:30 Doors open & Networking 19:00 Welcome & Introduction 19:05 Presentations by panelists 19:45 Panel discussion 20:15 Networking (There is a TV documentary coming up on Jan[masked] about death & digital that you might be interested in: "Unsterblich im Internet? Vom Umgang mit dem Tod in einer digitalen Welt" http://www.mdr.de/tv/programm/exaktdiestory100.html )
- Digital Health 2020: what is entering German Healthcare in the next 3 years?
Dear health 2.0 members, #1 if you are RSVPed and cannot make it, please UN-RSVP asap on our meetup platform to free your spot to someone from the waiting list. #2 doors open at 6:30pm at Spielfeld. We will have the RSVP list printed at 3pm on OCT 25th as our reference. Who is RSVP’ed and on location BEFORE 7pm is allowed to come in. #3 if you are on the waiting list and suspect a no-show from someone on the RSVP list, you can give it a try and come to the event location at your own risk: if we have free spots left due to no-shows on our RSVP list after 6:50pm, we will give away the spots to the people who are on location AND on the waiting list. #4 if you are RSVP’ed and arrive after 6:50pm, we cannot let you in due to the people who we share your free spot on the waiting list. #5 We’re sorry we cannot make an exception this time, no matter what title, relationship to us or bright smile you have. We appreciate your interest very very much and are looking forward to welcome you on time tomorrow at Roland Berger Spielfeld, kindly respecting the guidelines as stated above. +++ The digital transformation of healthcare has only just begun. Across Europe people use the benefits of electronic health records, AI assisted symptom checkers, certified med tech devices to continuously monitor body vitals to adjust their medication and share their data with their doctors. In Germany we look at our insurance chipcard with our address on it, we phone specialty doctors for an appointment and cry tears of happiness when we get one in 6 months. We still run with our doctor’s prescription on paper to the pharmacy next door, video consultation is doable but not available and we lose our network connection on our mobile phones when travelling from Berlin to Hamburg. We hear a lot of talking that our system is one of the best, but where exactly are the beneficial digital health products and services for Germany in the next 3 years? Join our panel discussion on what we can experience coming up until 2020. Discover best practice examples on how they are going to be implemented and find out if there’s still room for more. Agenda: 18:30 Doors open 18:50 doors close for RSVP'ed who don't show up on time, subscribers of waiting list on location get the free spots of the RSVP no shows. RSVP after 6:50 = no entry. 19:00 Welcome 19:10 Keynote Speech by Dr. Karsten Neumann, Roland Berger, Germany 19:20 Panel Discussion including Q&A from the audience with the following participants: Pharma: Dr. Hardy Kietzmann, Director Innovation, Sanofi in Germany Statutory Health Insurance: Jonas Pendzialek, Digital Transformation Manager, Die Techniker, Hamburg Private Health Insurance: Yvonne Gründler, Chief Product Officer, Ottonova AG, Munich Medical AI Startup: Baher al Hakim, CEO & Co-Founder, Medicus.ai, Vienna (AT) Medical Startup specialized on migraine indication: Markus Dahlem, Chief Medical Officer & Co-Founder M-Sense, Berlin Host & Moderator: Juliane Zielonka, Health 2.0 Berlin 20:30 Networking with Drinks & Snacks 21:30 Closing Panelists: Dr. Hardy Kietzmann, Director Innovation, Sanofi in Germany, Berlin @sanofiDE (https://twitter.com/@sanofide) Dr. Hardy Kietzmann is the Director of Innovation at Sanofi in Germany. Dr. Kietzmann has more than 18 years experience in the pharmaceutical industry. At Sanofi, he has held various positions in business development in Germany, such as Director of Strategic Projects and he was Head of Strategy and Product Transfer in Japan. Alongside his pharmaceutical knowledge and experience, Kietzman also brings 10 years knowledge of Production, Device Development, Strategic Analysis, and Sales & Marketing. He is also a member of Mensa Germany, holds a PhD in Experimental Physics and has served as a Lieutenant in the German AirForce. Jonas Pendzialek, Digital Transformation Manager, Statutory Health Insurer Die Techniker, Hamburg @JonasPendzialek (https://twitter.com/JonasPendzialek) @TK_Presse (https://twitter.com/TK_Presse) Jonas Pendzialek works as Digital Transformation Manager for Techniker Krankenkasse (TK). TK is the single largest health insurance company in Germany. His role is to coordinate and manage digital transformation projects for the TK internally and externally. Previous to that, he was working for B-LUE Management Consulting, a top management consulting firm, specialized in the health care industry. There, he advised health insurance companies, hospitals, pharmaceutical company and many other clients in the health care space on strategic and organizational issues.Jonas studied Business Administration and Economics at the Leibniz University in Hannover and at the ESC Rouen. He recently finished is dissertation in health economics on the topic of health insurance competition at the University Hospital Cologne. Yvonne Gründler, Chief Product Officer at ottonova AG, Germany’s first digital private insurer, Munich @ottonova_ag (https://twitter.com/ottonova_ag) @ygruendler (https://twitter.com/@ygruendler) Yvonne is responsible for Product Development at Ottonova. Ottonova is the first completely digital health insurance provider in Germany. The Munich-based startup provides full coverage private health insurance. It is centered around its app as the central hub for all its digital services. Baher Al Hakim, Co-Founder & CEO at Medicus AI, Vienna (AT) @medicusai (https://twitter.com/medicusai) Medicus converts health data (vitals, blood reports, device readings etc.) with their cryptic numbers and medical language into a visual experience with easy-to-understand health insights and actionable recommendations. Baher is a dentist by study and a serial entrepreneur by practice, with 13 years experience in a broad spectrum of disciplines including product & technology, sales, marketing and fundraising. Before Medicus, Baher founded CloudAppers digital agency in Dubai in 2008 with 100+ projects, from which he stepped down in 2015 to start Medicus. He also founded napkin startup studio in 2012 with $850,000 in funding, that prototyped, built and launched many products, a few of which were spun off as standalone companies. Most successful of them is Wally, a smart personal finance app that amassed 100,000 users within 2 months and become #1 finance app in 22 countries. Markus Dahlem, Chief Medical Officer & Co-Founder M-Sense, Berlin @msense_app (https://twitter.com/@msense_app) M-sense takes you through the steps of identifying the causes of your headache and migraine attacks and helps you avoid future attacks. As a theoretical physicist, Markus has researched the topic of migraines for more than 20 years. His computer models on the symptoms of irritation and neurological impairment from migraine can be found in medical text books. Besides this, Markus writes about current migraine research on his science blog as well as for various medical journals. +++ We thank our Sponsor SPIELFELD DIGITAL HUB for location sponsoring & catering. HOW TO GET TO SPIELFELD DIGITAL HUB: Spielfeld Digital Hub, 85-86 Skalitzer Straße, Entrance D (located at the side of the building) Directions: From U1 Schlesisches Tor, walk back towards Görlitzer Bahnhof keeping to the right side of the Ubahn track until you reach the old Post Office building. Seats are limited, so please RSVP now.
- The Future of Clinical Trials: The Good, the Bad and the Digital
As medicine grows more specialized and data-driven, the need to adapt and rethink the current medical affairs becomes imperative. At the same time, the health industry is moving to a new paradigm, Medical Affairs 2.0, where data mining combined with medical expertise are becoming critical for R&D and commercial counterparts and its role in product launch is getting strategically crucial. Based on a study presented by Bain company, clinician-scientists have reduced their reliance on pharma sales representatives turning to more scientific sources of information in the healthcare industry. That shift is even more pronounced among younger physicians. In parallel, the total number of sales representatives at big pharmas has fallen in the past years. The Internet of Things and emerging technologies offer many undeniable advantages to becoming the “new norm”. In regards to clinical research, data can be collected more easily and over longer periods of time. Overall, collaboration, cooperation and transparency will provide the new directions for clinical researchers. In collaboration with our long-term Health 2.0 Berlin friend Nana Bit-Avragim and some pioneering digital health companies such as Viomedo and Medicinisto, Charité–Universitätsmedizin Berlin, and Ernst & Young Germany, we are going to discuss innovations and current trends in clinical trials to reinvent key opinion leader management and build on value measures and progress towards data-driven, user-centric clinical trials operation. Agenda 18:30 Doors open 19:00 Welcome 19:10 Keynote Speaker: Dr. Prateek Mahalwar (https://de.linkedin.com/in/prateekmahalwar/de), Ernst & Young Germany 19:30 Panel Discussion with the following participants: • Prof. Dr. Marcus Maurer (http://www.marcus-maurer.com/index.php?id=837), Charité-Universitätsmedizin Berlin • Zsuzsanna Varga, PhD, Innovation Manager at Bayer • Alexander Puschilov (https://de.linkedin.com/in/puschilov), Viomedo GmbH • Guido Axmann (https://de.linkedin.com/in/guidoaxmann), Medicinisto AG • Dr. Katarina Braune (https://de.linkedin.com/in/dr-katarina-braune-64706345), Patient Representative Moderation: Dr. Nana Bit-Avragim (https://www.linkedin.com/in/nana-bit-avragim-70565665/), Medicinisto 20:30 Networking with Beer & Pretzels Speakers: Prateek Mahalwar, PhD Manager - Advisory Services, Ernst & Young GmbH http://www.ey.com/de/de/home Dr. Mahalwar is part of the Advisory Services practice of EY Germany, concentrating on the Life Sciences and Healthcare sector. His work includes advising biotechnology, pharma and MedTech companies on investment, product commercialization and digitization topics. Prateek Mahalwar holds a PhD in Life Science from Max Planck Society, where he was supervised by Nobel Laureate Prof. Christiane Nüsslein-Volhard. Prior to joining EY, Prateek has co-founded digital health and medical device start-up and also served as an advisory board member at eLife Sciences Ltd., UK (Max Planck, HHMI & Welcome Trust). Prateek has numerous years of experience in working with various C-level management executives internationally. Marcus Maurer, MD Charité - Universitätsmedizin Berlin, Department of Dermatology and Allergy, Germany, http://www.marcus-maurer.com/index.php?id=837 (http://www.marcus-maurer.com/index.php?id=837) Marcus Maurer is Professor of Dermatology and Allergy at the Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Germany. He is also the Director of Research at the Department of Dermatology and Allergy, Associate Director of the Allergie-Centrum-Charité, and Head of the Specialty Clinics for angioedema, hereditary angioedema, urticaria, mastocytosis, pruritus, autoinflammatory disorders and the Dermatological Allergology Laboratory. He trained in dermatology and allergology in Berlin and Mainz, and in experimental pathology at the Beth Israel Deaconess Hospital and Harvard Medical School in Boston from 1995 to 1998 and attained his board certification for dermatology in 2000 and allergology in 2003. His habilitation (“Why do we have mast cells?”) was undertaken at the University of Mainz in 2003. Professor Maurer´s research focuses on physiological and pathological functions of mast cells. He has made numerous important contributions to the understanding of the role of mast cells in the pathogenesis of chronic inflammatory disorders as well as in the protection from infections. His clinical emphasis is on urticaria, mastocytosis, angioedema, hereditary angioedema, pruritus, and auto-inflammatory syndromes. Lately, Professor Maurer’s team has also followed translational approaches using human in vivo and ex vivo models to investigate the functions of human mast cells, mostly skin mast cells. These investigations have led, among others, to the development of the concept of autoallergy in chronic urticaria, which was critical for the clinical testing and develop of anti-IgE as a novel treatment option in chronic spontaneous urticaria, a treatment that was licensed for the use in this disease in 2014. Professor Maurer’s team, over the past years, built national reference centres for the investigation and treatment of urticaria, mastocytosis, hereditary angioedema, angioedema and other mast cell-driven diseases, and more than 30 randomized controlled trials (phase I through IV) were performed by him and his team since 2011. Professor Maurer is the author of more than 415 publications in peer reviewed journals including Nature and the New England Journal of Medicine (>21,700 citations, h-index: 76). Alexander Puschilov Co-Founder and Managing Director of Viomedo https://www.viomedo.de/ Alexander is one of the founders of Viomedo. He is driven by the mission to provide patients with access to tomorrow’s medicine today. Before starting Viomedo, Alexander was amongst others with Rocket Internet and advised leading biotech companies on their market access strategy. He holds a M.Sc. in International Health Policy from the London School of Economics and a B.Sc. in Management from WHU. Guido Axmann Co-Founder and CEO of Medicinisto http://www.medicinisto.com/ A graduate in medicine, Guido Axmann is an entrepreneur, business developer and early-stage investor. He has created and developed several businesses and organizations in healthcare, sustainability and energy. Currently, he serves as co-founder and CEO of Medicinisto, the platform for medical expertise, where medicine meets the healthcare industry. Katarina Braune, MD Katarina Braune lives with type 1 diabetes since 2001, wearing a continuous glucose monitoring sensor system and an insulin pump. From her professional background, she is a medical doctor and researcher at the Department of Paediatric Endocrinology and Diabetes of Charité-Universitätsmedizin Berlin. Furthermore, she is fighting for global access to insulin and empowering young people to live with diabetes as a global advocate. She helped to set up Berlin's refugee health unit “Charité hilft” which has provided medical aid to more than 64,000 refugees. For future research projects, her focus is on digital health and telemedicine, building scientifically sound digital health solutions that grow on the real needs of real patients. Please have a look at Katarina’s story on challenges of refugees living with a chronic disease given by Katarina at TEDxUniHalle: https://youtu.be/A1oyHCOP9Pk Zsuzsanna Varga, PhD Innovation Manager at Bayer, Program Manager of Bayer Grants4Apps https://www.grants4apps.com/ Zsuzsanna grew up in Heidelberg, Germany. She holds a Biotechnology degree and obtained her PhD in Biomedical Sciences at the Mount Sinai School of Medicine in New York. During her studies she worked with several biotechnology start-ups and has experience in life sciences for 15 years. At Bayer she has been working as a Business Consultant for Marketing & Sales topics with a focus on digital patient support programs. Zsuzsanna is currently managing the Grants4Apps program for digital health start-ups with the aim to identify business opportunities for Bayer. Nana Bit-Avragim, MD Head of Strategic Relations at Medicinisto Dr. Nana Bit-Avragim is a medical expert, intrapreneur and digital health strategist. Nana is passionate about new life sciences technologies and believes that innovation means adapting to the future. To translate the latest global technological developments into life sciences and align it with the healthcare industry, Nana has successfully developed and executed a broad scope of innovative programs and partnerships between SMEs, NGOs, healthcare industry and academia in her previous roles as Director of Entrepreneurship and Innovation at Charité Foundation and Head of Digital Health & Life Sciences program at the German hub of Singularity University, an executive education organization based on NASA Research Park in Silicon Valley. Nana is currently leading business development and strategic partnerships at Medicinisto, an international business network for medical experts and healthcare industry.
- Mental Health & Technology
Welcome to a meetup where we discuss mental health and what technology can do in that space with startups in e-mental health, people with mental health difficulties, doctors, and you - the digital health community. We will be talking about how technology can support people with mental health difficulties - what low-level support and self-help can do, as well as how diagnosis and therapy can be supported by technology. The meetup will be in German. Agenda: 18:00 Networking 18:30 Panel discussion 1: Low-level support for people with mental health difficulties / Consumer focus 19:30 Panel discussion 2: Therapy support for people with mental health difficulties / Medical focus 20:30 Networking Panelists: Mark Goering, Moodpath (https://www.moodpath.de/de/) Nora Blum, Selfapy (https://www.selfapy.de/) Benjamin Vahle, Bluebird Technologies (http://www.blue-bird-tech.com/) Nadine Bittner, Aslan & TelePsy (https://www.telepsy.de/) Kristina Wilms, ARYA App (https://www.aryaapp.co/) Vivian Otto, Jourvie (http://www.jourvie.com/) Dr. rer. nat. David Daniel Ebert, Leiter Arbeitseinheit E-Mental Health, Lehrstuhl für Klinische Psychologie und Psychotherapie, Friedrich-Alexander Universität Erlangen Nürnberg (http://www.psych1.phil.uni-erlangen.de/team/mitarbeiterinnen/ebert/) Prof. Dr. med. Stefan Röpke, Oberarzt, Leiter des Bereichs Persönlichkeitsstörungen, Posttraumatische Belastungsstörung sowie der Autismusambulanz (https://psychiatrie.charite.de/fileadmin/user_upload/microsites/m_cc15/psychiatrie/Mitarbeiter/cvs/roepke/CV_Prof__Dr__med__Stefan_R%C3%B6pke.pdf) Moderator: Gerrit Brand & Inga Bergen The discussion will also be open to questions and comments from the audience. We especially welcome people with mental health difficulties and physicians / psychotherapists in the mental health space. Detailed information about panelists: Mark Goering, Moodpath Mark Goering (born 87 in Chicago, IL) holds a Masers degree in Psychology. He worked in several Berlin based startups in HR & Recruiting, before working as a psychotherapist at the Institute für Behavioral Therapy (IVB) and a psychiatric clinic in Berlin. By co-founding Aurora Health, he merged his two passions: Startups and Clinical Psychology. Aurora Health is a Berlin-based technology company providing digital solutions to improve the detection and treatment of mental health. The company’s solutions are Moodpath, a consumer-friendly mobile depression screening and improvement program, and Aurora, the underlying platform to support healthcare practitioners in diagnostic, therapeutic and administrative processes. Nora Blum, Selfapy Katrin Bermbach, Farina Schurzfeld und Nora Blum. Together, it is our goal to change the mental health care system so that all people suffering from psychological disorders get help in time. Selfapy offers online therapy courses against psychological disorders to make fast and affordable care accessible to everyone. Courses are effective at treating symptoms by combining technology with elements of traditional care. Benjamin Vahle, Bluebird Technologies Mithilfe neuester Technologie skalierbaren sozialen Mehrwert schaffen – dafür brennt Benjamin Vahle. Zwar hat er Management in Deutschland, den USA und Kanada studiert, doch eigentlich interessiert er sich viel mehr für Informatik, Physik und Psychologie. Gut dass er bei Blue Bird Technologies seine Leidenschaft, seine Interessen und sein Können kombinieren kann, um Menschen mit psychischen Erkrankungen ein besseres Leben zu ermöglichen. Blue Bird entwickelt einen App-basierten Therapieassistenten, der Menschen mit psychischen Erkrankungen im Alltag hilft, ihre Symptome zu managen und Krisen zu verhindern. Der Fokus liegt hierbei auf der Unterstützung von Menschen mit chronischen Erkrankungen, die langfristig Unterstützung benötigen. Nadine Bittner, Aslan& and TelePsy Nadine Bittner ist klinische Psychologin und hat als Head of Therapy für das E-Mental-Health Start-Up humly gearbeitet. Derzeit baut sie als Business Development Managerin das Deutschlandgeschäft für das E-Health Unternehmen TelePsy Deutschland auf, ist Gründerin des Sozialunternehmens Aslan& und Stipendiatin des Startery-Programms des Social Impact Labs und SAP. Aslan& supports you in times of crisis – through trustworthy peers who have gone through similar struggles and can share their experiences with you. TelePsy wurde 2010 in Kooperation mit verschiedenen Hausärzten, Psychotherapeuten und Psychiatern in den Niederlanden gegründet. Das Ziel ist, die Gesundheitsfürsorge mit Hilfe von digitalen Instrumenten besser und effizienter zu machen. Dieser Ansatz wird auch als Blended Care bezeichnet und meint die Integration digitaler Inhalte in die konventionelle Psychotherapie. Vivian Otto, Jourvie Vivian Otto holds a MSc in Business and supports Jourvie in the fields of operations and business development. Having previously gained experience in optical hardware and business software, she now combines her passion for health with past experience. Jourvie strives to facilitate the everyday life of patients suffering from eating disorders such as anorexia, bulimia and binge eating. It complements traditional therapeutic approaches and was developed along the guidelines of Cognitive Behavioural Therapy. Eating disorders aren't simply a reluctance towards food but psychosomatic illnesses with high comorbidities with depressions and anxiety disorders. With the Jourvie app, patients can easily and discreetly record meals, emotions and obtain support as well as motivation through coping strategies between therapy sessions. Dr. rer. nat. David Daniel Ebert, Leiter Arbeitseinheit E-Mental Health, Lehrstuhl für Klinische Psychologie und Psychotherapie, Friedrich-Alexander Universität Erlangen Nürnberg Dr. David Daniel Ebert´s work focuses on the development and evaluation of internet and mobile-based behavioral health technology interventions. He is President elect of the International Society for Research on Internet Interventions, co-founded the GET.ON Institute for health trainings online, a start-up which aims to transfer evidence-based eMental Health Intervention in routine mental health care. He received his PhD with special honors (summa cum laude) and was trained from the Philipp’s-University of Marburg, Germany, the Free University Amsterdam and Harvard University Boston. He was formerly head of the division for Health Trainings Online at the Leuphana University Lueneburg, Germany, leads now the E-Mental Health unit at the Friedrich-Alexander University Erlangen-Nuremberg and is scientific advisor of many national and international companies, such as Lantern Inc. Prof. Dr. med. Stefan Röpke, Oberarzt, Leiter des Bereichs Persönlichkeitsstörungen, Posttraumatische Belastungsstörung sowie der Autismusambulanz Gerrit Brand Gerrit Brand ist Arzt in einer Klinik für Psychiatrie, Psychotherapie/-somatik u. Suchtmedizin der GLG. Vor seiner Rückkehr in die klinische Medizin hat er für viele Jahre in der Pharmazeutischen Industrie und Biotechnologie in Deutschland, Kanada und den USA gearbeitet und war Co-Founder eines Biotechnologie-Startups in Research Triangle Park und Santa Monica, CA. Gerrit hat der Charité in Berlin promoviert.
- Interoperabilität: Mobile Health vernetzen mit Praxis- und Kliniksystemen
(Event will be in German) Potentiell behandlungsrelevante mHealth-Anwendungen müssen mit Praxis- und Kliniksystemen kommunizieren können. Dem Arzt das Smartphone zu zeigen oder Gesundheitsdaten ungesichert per E-Mail oder über WhatsApp zu senden sind keine gangbaren Wege im Gesundheitsbereich. Eine für den Behandlungskontext relevante App muss also nicht nur stand-alone funktionieren, vielmehr muss die App ihre Daten auch an die IT-Systeme einer Praxis oder eines Krankenhauses übertragen oder von dort abrufen können. Nicht zu vernachlässigen sind außerdem andere Heilberufe wie beispielsweise die Pflege und die dort relevanten Systeme. Ein zentrales Prinzip bei der Entwicklung von Schnittstellen zwischen IT-Systemen ist das der Interoperabilität, welche durch das Einhalten gemeinsamer Standards ermöglicht wird. Die Umsetzung einer Schnittstelle, über die App-Hersteller auf der einen Seite und KIS- und PVS-Hersteller auf der anderen Seite miteinander kommunizieren können, führt neben einer fehlerfreien Übermittlung auch zu Kostensenkungen und zu einer flexibleren Nutzung und größeren Verbreitung von Apps. Welche Standards sind nun für die Anbindung von mHealth-Anwendungen an KIS- oder PVS-Systeme relevant? In der klassischen digitalen Gesundheitswirtschaft spielen die Standards von HL7 (Health Level Seven) und IHE (Integrating the Healthcare Enterprise) eine zentrale Rolle, mHealth wird über den neuen HL7 Standard FHIR (Fast Healthcare Interoperability Ressources) abgebildet. Das Meet-Up „Interoperabilität: Mobile Health vernetzen mit Praxis- und Kliniksystemen“ gibt Teilnehmern - also einerseits Startups aus dem Bereich mHealth, sowie andererseits den im Bundesverband Gesundheits-IT - bvitg e. V. organisierten Softwareherstellern aus den Bereichen KIS und PVS, die Möglichkeit, mehr über die technischen Themen FHIR und IHE zu erfahren. KIS- und PVS-Hersteller des Bundesverbands Gesundheits-IT stellen ihre Sicht auf das Thema Mobile Apps und deren Integration in ihre Systeme dar. Vor allem aber soll der Abend den Teilnehmern aus den beiden Welten die Möglichkeit geben, miteinander ins Gespräch zu kommen, neue Kontakte zu knüpfen und neue Ideen und Kooperationen zu entwickeln. ========================================================= Agenda 18:30Uhr: Open Doors 19:00 Uhr: Begrüßung (Ekkehard Mittelstaedt, bvitg e.V. + Vertreter Health 2.0 Berlin & HealthCapital) 19:05 Uhr: Vorträge (jeweils 15 Minuten) - Smarte Kommunikation mit niedergelassenen Ärzten (Rico Tetmeyer, medatixx GmbH & Co. KG) - Apps, Mobile, mHealth – Interoperabilität aus KIS Perspektive (Sarah Peuling, Cerner Deutschland) - FHIR – was ist das? (Dr. Frank Oemig, Telekom Healthcare Solutions/ HL7 Deutschland e. V.) - IHE und FHIR-Profile (Dr. Ralf Brandner, InterComponentWare AG / IHE Deutschland e. V.) ca. 20:05 Uhr: Come together ========================================================= Kurzportraits der Referenten Rico Tetmeyer Diplominformatiker und seit 2009 bei der Firma medatixx tätig, dort hat er an Projekten und Kooperationen in verschiedenen Größen und Ausprägungen mitgewirkt. Standards wie HL7 haben ihn schon im Studium begleitet, daher ist er 2014 beim bvitg in der AG Interoperabilität aktiv geworden und verantwortet seit 2016 die Abteilung „Standards & Schnittstellen“. In dieser Funktion ist er auch technischer Ansprechpartner für den „medatixx appPoint“. Sarah Peuling Strategist im Center of Competence Innovation & Clinicals bei Cerner für den deutschen Markt und auf der Suche nach innovativen Software-Lösungen und -Konzepten für den deutschen Gesundheitsmarkt. Davor zwei Jahre Erfahrungen bei Cerner im Business Management für die Produktlinie medico® und Koordination der Markteinführungsstrategie der neuen mobilen Lösung von Cerner. Master of Science / Diplom-Ingenieurin Elektrotechnik an der Technischen Universität München mit Schwerpunkt Robotik und Mensch Maschine-Interaktion. Dr. Frank Oemig Nach dem Studium der Informatik mit dem Nebenfach theoretische Medizin und dem Abschluss Diplom hat Hr. Oemig mehrere Jahre im Bereich ICT gearbeitet. Durch die Studien begleitenden Tätigkeiten hat Hr.Oemig inzwischen fast 35 Jahre Erfahrung im Bereich Informationstechnologie, davon entfallen 34 auf Healthcare IT und 26 auf Informations- und Kommunikationstechnologie (ICT) für Healthcare.1993 begann Hr.Oemig sich dann für den Datenaustausch im Gesundheitswesen zu interessieren, was zur Beschäftigung mit Fragen der semantischen Interoperabilität (HL7, IHE und DICOM) geführt hat. Auf diesem Gebiet promovierte er dann auch 2011. Seit kurzem ist er bei der Deutschen Telekom Healthcare and Security Solutions GmbH als eHealth Architekt beschäftigt. Dr. Ralf Brandner studierte bis 1998 Medizinische Informatik an der Universität Heidelberg und der Fachhochschule Heilbronn. Anschließend arbeitete er am Universitätsklinikum Heidelberg als wissenschaftlicher Mitarbeiter und promovierte 2002 er an der Universität Heidelberg. Dr. Ralf Brandner ist seit 2004 bei der ICW in verschiedenen Verantwortungsbereichen tätig. Seit 2013 ist er Geschäftsbereichsleiter und im gleichen Jahr wurde ihm die Prokura erteilt. Darüber hinaus ist Dr. Ralf Brandner in leitenden Funktionen von HL7 Deutschland, IHE Deutschland und der AG Interoperabilität des bvitg. ========================================================= Das Meetup ist eine Gemeinschaftsveranstaltung von Health 2.0 Berlin mit dem Bundesverband Gesundheits-IT (bvitg (http://www.bvitg.de/)) und dem Cluster Gesundheitswirtschaft Berlin-Brandenburg (healthcapital.de (http://www.healthcapital.de/)). Wir danken medatixx (https://medatixx.de/) für die Bereitstellung ihrer Räumlichkeiten in Berlin.
- New Year’s Resolutions for 2017: An Invitation to Healthy Aging
We are starting the year with a celebration - Health 2.0 Berlin is 5! And we are celebrating with a meetup: In the time of constant (exponential) movement, nothing is so exciting as to staying healthy as we age. Still, despite real progress in medicine helping us to live healthier and longer than ever, there is no magic bullet in sight that could turn years back or even stop aging. If we conquer illness, can we also look at aging as such? What if we rethink our current understanding of aging by beginning at the cellular level and reorganizing our body’s ability to regenerate? How artificial intelligence and robotics are having a transformative impact on a process of aging? And what are the ways to disrupt longevity? There are still plenty of unanswered questions and so much to do! With support of Health 2.0 Berlin, SingularityU Berlin Chapter presents its first chapter event and together with international leading experts in medicine, life sciences, entrepreneurship and IT technologies would like to invite you to an exciting journey in the world of “healthy aging”. We will start with a comprehensive overview on aging given by Maneesh Juneja (http://maneeshjuneja.com) , Digital Health Futurist from London, UK followed by a panel discussion with Prof. Hans-Christian Gunga (http://charite-in-space.de/portfolio/hanns-christian-gunga), Center for Space Medicine and Extreme Environments at Charite, Berlin, Germany; Dr. Sara Wickström (https://www.age.mpg.de/science/research-labs/wickstroem/cv), Max Planck Institute for Biology of Ageing, Cologne, Germany; John Crawford (https://uk.linkedin.com/in/johncrawfordibm/de) IBM Watson Healthcare Technology Europe; Daniel Nathrath (https://ada.com), Founder and CEO of Ada Digital Health Ltd., UK/Germany. Agenda: 18:30 Doors open 19:00 Welcome and Intro 19:10 Presentation by Maneesh Juneja 19:40 Panel discussion 20:45 Networking Speaker: Maneesh Juneja (http://maneeshjuneja.com) Digital Health Futurist from London, UK Maneesh Juneja is a Digital Health Futurist who explores the convergence of emerging technologies to see how they can make the world a healthier and happier place. In 2016, he was ranked 7th most influential in Digital Health, and at the beginning of 2015, Maneesh Juneja was ranked 10th most influential in Wearable Technology. In 2012, he left the security of his career at GlaxoSmithKline, to immerse himself in the new world of Digital Health. In the same year, Maneesh also founded the Health 2.0 London Chapter, which has since become the UK’s largest grassroots health tech community. In a career spanning 20 years, Maneesh has worked with data to improve decision-making across a number of industries. From supporting the Whitehall study at University College London, managing the Tesco database at DunnHumby, and most recently, working with the world’s largest U.S. & European patient databases at GlaxoSmithKline R&D. Prof. Hans-Christian Gunga (http://charite-in-space.de/portfolio/hanns-christian-gunga), Center for Space Medicine and Extreme Environments at Charite, Berlin, Germany Prof. Gunga started his career at the Department of Physiology at the Free University of Berlin, Germany in 1987 with experimental and clinical cardio-vascular studies in humans such as during bed rest, head-down tilt and extensive physical exercise. He performed studies on intravascular-interstitial fluid shifts, plasma volume and red blood cell mass control as well as renal physiology in humans under extreme environmental and physical conditions including research in Antarctica and space. The results have been published in high ranked scientific journals such as Journal of Applied Physiology, Lancet, and Proceedings of the National Academy of Sciences. Since 2001 Gunga focused his research fields on thermoregulation and heat balance in humans in extreme environments. He has been involved in several space missions (D-1, D-2, MIR, ISS) and is currently ESA Principal Investigator of the Circadian Rhythm experiment on the International Space Station which will last until 2018. His recent published books “Nathan Zuntz” and “Human Physiology in Extreme Environments” received the “Life Science Book Award” of the International Academy of Astronautics (IAA) in 2010 and 2015, respectively. Prof. Gunga is currently deputy director of the Department of Physiology of the Charite University Medicine Berlin, speaker of the Center of Space Medicine and Extreme Environments, and among others Member of Wissenschaftlicher Beirat für das Sanitäts- und Gesundheitswesen beim Bundesminister für Verteidigung (Wehrmedizinischer Beirat) (Medical Advisory Board of the Military Medical Service of the German Federal Ministry of Defense) and Chairman of the “Programausschuss des Deutschen Zentrums für Luft- und Raumfahrt (DLR)”. Dr. Sara A. Wickström (http://www.age.mpg.de/science/research-labs/wickstroem/), Max Planck Research Group Leader, Max Planck Institute for Biology of Ageing, Cologne, Germany Sara Wickström studied medicine at the University of Helsinki, Finland and absolved a M.D/PhD. program receiving her MD in 2001 and PhD in 2004. In 2010 she was appointed as a Max Planck Research Group Leader at the Max Planck Institute for the Biology of Ageing in Cologne, Germany. Her research addresses a set of fundamental questions in the fields of regenerative medicine and cancer biology: What are the mechanisms that control the stem cell state? How can this phenotype be dynamically adapted to the changing need of an organ/organism? How are the unique properties of stem cells harnessed during malignant transformation and compromised during aging? Her group uses mammalian skin epidermis as a model to study how stem cell behaviour, tissue morphogenesis, and homeostasis is controlled by cell and tissue-level mechanics as well as by chemical and physical interactions between different cell types and the extracellular matrix. In addition, she investigates how these processes are perturbed during ageing and age-related disease such as cancer. John Crawford (https://uk.linkedin.com/in/johncrawfordibm/de) IBM Healthcare Industry Expert & IBM Industry Academy Member John is a member of IBM’s global Healthcare and Life Sciences Industry team, with a specific focus on the European market. He is also a member of the IBM Industry Academy, and the IBM Faculty Academy. He advises and contributes to a number of European and Global healthcare IT industry associations, including COCIR, Continua. He is the lead IBM contributor for the European Innovation Partnership on Active and Healthy Aging (Action Area B3 – Integrated Care), and is one of several IBM executive sponsors of EIT Health, a European alliance for healthy living and active ageing. John is President, since January 2016, of the European Health Telematics Association (EHTEL), a multi-stakeholder membership organisation dedicated to the promotion of eHealth and new models of care. He is also a Board Member of HIMSS for the period April 2016 to June 2018. He is often invited to provide expert commentary about developments in eHealth, Big Data and Analytics, and has spoken at many conferences and events over the past 10 years. These include HIMSS conferences in Europe and the USA, the European Health Forum Gastein, EU eHealth Week, the HIMSS CIO Summit, the European Telemedicine Conference, the European Society of Cardiology Congress, and the NHS Confederation Conference. In 2012 he contributed to the World Economic Forum report on Sustainable Healthcare Systems. He also edited the chapter on ‘Open Innovation in eHealth’ for the InnovaHealth report published by the Cyprus Presidency in 2012 With over 35 years experience in the IT Industry, he is a strong advocate for the transformation of healthcare using information technology, and he regularly briefs press and analysts on IBM’s Healthcare Business, eHealth and Digital Health. Daniel Nathrath (https://ada.com), Founder and CEO of Ada Digital Health Ltd., UK/Germany Daniel has lived and worked in Germany, Denmark, the UK and the USA as Founder, Managing Director and General Counsel at several internet startups. He also spent some years as a Consultant at the Boston Consulting Group. He trained as a lawyer in Germany and the USA, where he was a Fulbright Scholar, and earned his MBA from the University of Chicago. About SingularityU Berlin Chapter: SingularityU Berlin Chapter is a local chapter and community organization of Singularity University (SU). SU is the benefit corporation behind a global community of innovators who share a mission to solve the world's greatest challenges. The SU Community comprises individuals, business, institutions, investors, and NGOs in over 110 countries. The SU platform is a unique combination of services that consists of educational programs in exponentially advancing technologies, as well as innovation programs to support collaboration and initiatives leveraging those technologies to positively impact billions of lives globally.
- Annual VC Panel Digital Health
The annual Health 2.0 Berlin VC panel is back! Meet Microsoft Ventures, Holtzbrinck Ventures, Asklepios and DHV on stage, when our host Juliane asks for latest trends, latest investments and future scenarios in Digital Health throughout Germany, Europe and US. The panel covers 3 parts: trends on startup side, trends on VC side, future outlook 2020, followed by a Q&A with the health 2.0 audience. PANELISTS Stefan Peters - Managing Director Holtzbrinck Digital GmbH Stefan is one of the Managing Directors of Holtzbrinck Digital and responsible for the Digital Publishing and Digital Health activities. While working closely with his companies like gutefrage.net, pflege.de and the netdoktor group he is continuously sourcing and evaluating investment opportunities in the Digital Health and Digital Publishing space. Before he joined Holtzbrinck in 2012, Stefan led several M&A transactions as part of Axel Springer's M&A core team and was responsible for the investment management of content & community activities within the Electronic Media Division of Axel Springer. Stefan studied Business Administration at the University of Hamburg and started his career with Ernst & Young as a consultant in the transaction advisory unit. Oliver Rong - Group Head of Strategy and Corporate Development Asklepios Kliniken GmbH Oliver joined Asklepios in November 2013. Prior to that he spent 16 years at an international strategy consulting firm and was as Partner since 2008 in charge of the health care practice in the DACH region. Before focusing on health care he advised clients in the field of public services and restructuring/corporate finance. At Asklepios besides the strategy development Mr. Rong coordinates the classic M&A issues (hospital, rehabilitation, etc.) and as a new field also the investment in health care startups contributing to Asklepios’ value chain. Stephan Jaquemot - Startup Strategy Lead Germany at Microsoft Accelerator At Microsoft Stephan Jacquemot is responsible for Microsoft´s startup activities in Germany. He also built the Microsoft Accelerator in Berlin and the Customer Access Program (CAP) for startups. Prior to that, Stephan co-founded an investment and consulting firm in the Kingdom of Bahrain. Since startups are his world, he founded, invested in and consulted startups throughout his career. Stephan Jacquemot holds a master’s degree with distinction in business administration from Cologne University. Clara Leonard - Associate Digital Health Ventures / DHV Management GmbH Clara Leonard is an Associate at Digital Health Ventures (DHV). Prior to joining DHV, Clara worked at Sanofi in San Francisco and Paris as a scout and project leader for Digital Health solutions. She gained a sharp knowledge of the Digital Health ecosystem by sourcing opportunities for partnerships with cutting edge startups and actively contributed to large scale projects such as the joint venture between Verily (former Google Life Sciences) and Sanofi in Diabetes management. She also acquired operational startup experience in a Business Development role at a French tech startup which successfully qualified for Y Combinator. Clara holds a double Master degree in Management from HEC Paris and Ecole Polytechnique, with a specialization in Project Management and Innovation. She studied and interned in France, Germany and Australia, where she earned experience in Strategy Consulting and Private Equity. HOST Juliane Zielonka - Health 2.0 Berlin Co-Organizer, Managing Director Startupbootcamp Digital Health Berlin Juliane Zielonka is the Managing Director of Startupbootcamp Digital Health Berlin, an industry focused 3-month accelerator program. Her mission is to empower Digital Health startups to economic growth. She has a proven track record in Digital Health, being the founder of a female health portal specialized on fertility threatening diseases that connects advice seeking women with specialty physicians. She is a co-organizer of the Health 2.0 Berlin chapter and host of this event. AGENDA 6:30pm doors open 7:00pm Welcome Introduction Microsoft Startup Activities 7:15pm panel discussion Part 1: trends on startup side Part 2: trends on investment side Part 3: future outlook digital health businesses in 2020 8:14pm Q&A from audience 8:45pm networking, drinks & snacks sponsored by Microsoft 10:00pm closing and farewell